AMERICAN JOURNAL OF MEDICAL GENETICS PART A

Scope & Guideline

Bridging Research and Clinical Practice in Genetics

Introduction

Welcome to the AMERICAN JOURNAL OF MEDICAL GENETICS PART A information hub, where our guidelines provide a wealth of knowledge about the journal’s focus and academic contributions. This page includes an extensive look at the aims and scope of AMERICAN JOURNAL OF MEDICAL GENETICS PART A, highlighting trending and emerging areas of study. We also examine declining topics to offer insight into academic interest shifts. Our curated list of highly cited topics and recent publications is part of our effort to guide scholars, using these guidelines to stay ahead in their research endeavors.
LanguageEnglish
ISSN1552-4825
PublisherWILEY
Support Open AccessNo
CountryUnited States
TypeJournal
Convergefrom 1996 to 1999, 2001, from 2003 to 2024
AbbreviationAM J MED GENET A / Am. J. Med. Genet. A
Frequency12 issues/year
Time To First Decision-
Time To Acceptance-
Acceptance Rate-
Home Page-
Address111 RIVER ST, HOBOKEN 07030-5774, NJ

Aims and Scopes

The American Journal of Medical Genetics Part A focuses on the genetic aspects of human diseases, emphasizing the role of genetics in medical practice, research, and education. It aims to provide a platform for the publication of original research, reviews, and case reports that advance the understanding of genetic disorders and their implications for health care.
  1. Genetic Disorders and Syndromes:
    The journal covers a wide range of genetic disorders, including but not limited to chromosomal abnormalities, single-gene disorders, and multifactorial conditions. It focuses on the clinical, molecular, and genetic aspects of these disorders.
  2. Clinical Genetics and Genetic Counseling:
    It emphasizes the importance of genetic counseling and clinical genetics in managing inherited conditions, highlighting the need for effective communication of genetic information to patients and families.
  3. Phenotype-Genotype Correlations:
    The journal explores the relationship between genetic variations and phenotypic outcomes, providing insights into how specific genetic mutations can lead to particular clinical features.
  4. Advancements in Genetic Testing:
    Research on the latest advancements in genetic testing technologies, including next-generation sequencing and their applications in clinical settings, is a central theme.
  5. Ethical, Legal, and Social Implications:
    It addresses the ethical considerations surrounding genetic testing and counseling, including patient privacy, consent, and the implications of genetic information on individuals and families.
  6. Multidisciplinary Approaches to Genetic Disorders:
    The journal promotes the integration of knowledge from various fields, including pediatrics, neurology, oncology, and other specialties, to enhance the understanding and management of genetic disorders.
Recent publications in the American Journal of Medical Genetics Part A indicate emerging themes and trends reflecting current research priorities in medical genetics. These areas highlight the evolving landscape of genetic research and its clinical applications.
  1. Integrative Genomic Medicine:
    There is a growing trend towards integrative approaches that combine genomic data with clinical information to enhance diagnosis and treatment strategies for genetic disorders.
  2. Neurodevelopmental Disorders:
    Research focusing on neurodevelopmental disorders, particularly those with complex genetic underpinnings, is increasingly prominent, reflecting heightened interest in understanding autism spectrum disorders and related conditions.
  3. Ethical and Social Implications of Genetic Testing:
    The journal is seeing more articles addressing the ethical, legal, and social implications of genetic testing, particularly in the context of direct-to-consumer testing and the responsibilities of healthcare professionals.
  4. Genetic Contributions to Common Diseases:
    There is a rising interest in exploring the genetic contributions to common diseases, including multifactorial disorders, as researchers aim to elucidate the complex interactions between genetics and environmental factors.
  5. Innovations in Gene Therapy:
    Research articles detailing advancements in gene therapy and its applications for treating various genetic disorders are increasingly featured, showcasing the potential of innovative therapeutic strategies.
  6. Longitudinal Studies on Genetic Conditions:
    An emerging trend is the publication of longitudinal studies that track the progression of genetic disorders over time, providing valuable insights into their natural history and management.

Declining or Waning

While the journal consistently covers a broad spectrum of genetic research, certain themes appear to be declining in prominence. This may reflect shifts in research focus or advancements in technology that render some areas less relevant.
  1. Traditional Cytogenetics:
    There is a noticeable decrease in publications focusing solely on traditional cytogenetic techniques, such as karyotyping, as advancements in genomic technologies like next-generation sequencing have taken precedence.
  2. General Genetic Education:
    Articles dedicated to general genetic education for healthcare providers are becoming less frequent, as the field shifts towards more specialized and targeted genetic education.
  3. Case Reports of Common Genetic Disorders:
    As the journal increasingly emphasizes rare and complex genetic disorders, the publication of case reports on more common genetic conditions is waning.
  4. Basic Genetic Research:
    The focus on fundamental genetic research, such as the molecular biology of genes without direct clinical applications, is less prevalent compared to applied genetic research with immediate clinical implications.
  5. Phenotypic Descriptions without Genetic Correlation:
    There is a decline in articles that describe phenotypes without linking them to genetic findings, as the emphasis shifts towards genotype-phenotype correlations and molecular mechanisms.

Similar Journals

GENETIC EPIDEMIOLOGY

Pioneering Research at the Intersection of Genetics and Epidemiology
Publisher: WILEYISSN: 0741-0395Frequency: 8 issues/year

GENETIC EPIDEMIOLOGY is a pioneering journal published by Wiley that bridges the fields of genetics and epidemiology to advance our understanding of the genetic underpinnings of health and disease. Established in 1984 and converging into its 40th year of impactful research in 2024, this journal offers a key platform for the dissemination of innovative research findings, statistical methods, and applications in both clinical genetics and epidemiological practices. With a robust presence in Scopus, ranking in the second quartile (Q2) for both epidemiology and clinical genetics, it enjoys a significant reputation among its peers. The journal does not currently offer open access, but it is vital for researchers, professionals, and students committed to exploring the evolving landscape of genetic influences on population health. Its rich repository of studies not only enhances knowledge but also informs public health policies and clinical practices worldwide, making it an indispensable resource for those seeking to innovate and apply genetic research in the quest for better health outcomes.

European Journal of Medical Genetics

Bridging Laboratory Discoveries with Clinical Practice
Publisher: ELSEVIERISSN: 1769-7212Frequency: 4 issues/year

European Journal of Medical Genetics, published by Elsevier, is a pivotal platform dedicated to advancing knowledge in the fields of medical genetics and its clinical applications. With an ISSN of 1769-7212 and an E-ISSN of 1878-0849, this journal fosters innovative research and insights into the genetic factors that influence human health. Ranked in the Q3 category for both Genetics and Clinical Genetics, and achieving notable recognition in Medicine (miscellaneous) with a Q2 positioning, it strives to bridge the gap between laboratory findings and clinical practice. Operating in an Open Access format, the journal aims at maximally disseminating essential findings to researchers, professionals, and students alike, ensuring that critical advances in genetics are accessible to the global medical community. With converged publication years spanning from 2005 to 2024, the journal strengthens its mission to be at the forefront of genetic research that informs clinical methodologies and fosters improved healthcare outcomes.

GENETICS IN MEDICINE

Leading the Charge in Clinical Genetics
Publisher: ELSEVIER SCIENCE INCISSN: 1098-3600Frequency: 12 issues/year

GENETICS IN MEDICINE, published by Elsevier Science Inc, stands as a premier journal in the realms of clinical genetics and medicine. With an impressive impact factor and ranked #3 out of 99 in the category of Genetics (clinical), alongside a 97th percentile ranking in the Scopus database, this journal is recognized for its outstanding contribution to the field. Established in 1998, it aims to disseminate innovative research and clinical advancements bridging genetics and medical practice, making it essential reading for researchers, healthcare professionals, and students alike. Although not an open-access journal, GENETICS IN MEDICINE provides valuable insights into genetics that drive the future of personalized medicine and patient care. With a commitment to excellence, the journal continuously explores the evolving landscape of genetic research to foster the understanding and application of genetic principles in medical contexts.

Journal of Community Genetics

Exploring the intersection of genetics and public health.
Publisher: SPRINGER HEIDELBERGISSN: 1868-310XFrequency: 4 issues/year

The Journal of Community Genetics, published by SPRINGER HEIDELBERG, is an influential Open Access journal dedicated to advancing the field of genetics in community settings. Since its inception in 2000, this journal has provided a platform for comprehensive interdisciplinary research that encompasses the critical intersections of genetics, public health, and epidemiology. Situated in Germany, the journal has positioned itself prominently within the academic community, evidenced by its 2023 impact rankings, which place it in the Q3 category for both Epidemiology and Genetics (clinical) and Q2 for Public Health, Environmental and Occupational Health. With an expanding scope that includes innovative research from 2010 to 2024, the journal aims to foster dialogue among researchers, healthcare professionals, and policymakers, ultimately driving advancements in community health genetics. The open access model ensures that this vital information is readily available to a global audience, reinforcing its commitment to public health improvement and genetic literacy.

INTERNATIONAL JOURNAL OF HUMAN GENETICS

Cultivating Knowledge in Genetics and Beyond
Publisher: KAMLA-RAJ ENTERPRISESISSN: 0972-3757Frequency: 4 issues/year

INTERNATIONAL JOURNAL OF HUMAN GENETICS is a distinguished publication dedicated to advancing knowledge in the fields of genetics and molecular biology. Published by KAMLA-RAJ ENTERPRISES, this journal explores critical developments and research findings from 2008 to 2016, though its coverage in Scopus has since been discontinued. With an ISSN of 0972-3757 and an E-ISSN of 2456-6330, the journal aimed to foster scholarly dialogue and serve as a resource for researchers, professionals, and students engaged in human genetics. While the journal holds a modest ranking in categories such as Biochemistry and Genetics, it remains a vital source for exploring niche topics within the realm of human genetics. Researchers interested in genetic screening, gene therapy, and clinical genetics will find valuable insights herein. Despite its pause in indexing, the journal continues to contribute to the academic discourse by disseminating critical research that bridges gaps in understanding human genetics.

Neurology-Genetics

Bridging the Gap Between Neurology and Genetics.
Publisher: LIPPINCOTT WILLIAMS & WILKINSISSN: 2376-7839Frequency: 6 issues/year

Neurology-Genetics, an esteemed journal published by LIPPINCOTT WILLIAMS & WILKINS, is at the forefront of advancing the fields of neurology and genetics. With a dedicated Open Access model since 2015, this journal ensures that cutting-edge research is readily available to researchers, professionals, and students worldwide. Operating from the United States, Neurology-Genetics has established a reputable position within the scientific community, as reflected by its impressive rankings in Scopus; it holds a Q1 ranking in clinical neurology and a Q2 ranking in clinical genetics, showcasing its dual commitment to these intertwined fields. With an impact factor that continues to grow alongside its reach, the journal encourages the dissemination of novel findings, innovative methodologies, and critical reviews that contribute to the understanding and treatment of neurological and genetic disorders. Researchers and practitioners are invited to engage with the latest discoveries and discussions, making Neurology-Genetics an essential resource for anyone involved in these dynamic areas of study.

Molecular Syndromology

Exploring the Intersection of Genetics and Syndromes
Publisher: KARGERISSN: 1661-8769Frequency: 6 issues/year

Molecular Syndromology is a premier journal focused on the intricate connections between molecular genetics and syndromology, fostering discussions that advance our understanding of genetic disorders and their clinical implications. Published by KARGER, a distinguished name in medical and scientific publishing, this journal serves as a valuable platform for researchers, clinicians, and students in the field of genetics. With its ISSN 1661-8769 and E-ISSN 1661-8777, the journal has gained recognition in its category, currently positioned in the Q4 quartile for both genetic and clinical genetics disciplines according to the latest metrics. Despite being indexed lower in Scopus rankings, it addresses crucial gaps in research and offers open access options that enhance visibility and dissemination of knowledge. As it continues to converge from 2010 to 2024, Molecular Syndromology aims to bridge the gap between molecular research and its clinical applications, making a significant impact in the evolving landscape of genetic medicine.

Egyptian Journal of Medical Human Genetics

Pioneering research in human genetics for global impact.
Publisher: SPRINGERNATUREISSN: 1110-8630Frequency: 1 issue/year

The Egyptian Journal of Medical Human Genetics is a distinguished Open Access journal published by SPRINGER NATURE, dedicated to advancing the field of medical human genetics. With an ISSN of 1110-8630 and an E-ISSN of 2090-2441, this journal serves as a vital platform for researchers, professionals, and students who are committed to the exploration of genetic implications on human health. Since its inception in 2010, it has become a growing repository of knowledge, significantly contributing to the discourse in clinical genetics, despite currently being ranked in the Q4 quartile of its category in 2023. The journal embraces an open access model, ensuring widespread visibility and accessibility of published research, thereby fostering collaboration and innovation in the field. The journal is not only aimed at disseminating findings but also at encouraging the dialogue around genetic research developments, making it an essential resource for anyone interested in the nuances of genetics and its impact on medicine.

EUROPEAN JOURNAL OF HUMAN GENETICS

Connecting Researchers in the Field of Human Genetics
Publisher: SPRINGERNATUREISSN: 1018-4813Frequency: 12 issues/year

The EUROPEAN JOURNAL OF HUMAN GENETICS, published by SpringerNature, stands as a preeminent platform in the field of genetics and clinical genetics. Established in 1993, this prestigious journal, with an ISSN of 1018-4813 and an E-ISSN of 1476-5438, has consistently maintained its position in the Q1 quartile for both Genetics and Clinical Genetics categories as of 2023, reflecting its significant contributions to the field. Its impact is further underscored by its impressive Scopus rankings, placing it in the 92nd percentile among clinical genetics journals. The journal aims to disseminate cutting-edge research, case studies, and reviews that advance our understanding of human genetics, promoting collaboration and innovation among researchers, professionals, and students alike. While it does not currently offer open access, the journal provides substantial value through its rigorous peer review process and commitment to quality. As it continues to shape the future of genetic research through 2024 and beyond, the EUROPEAN JOURNAL OF HUMAN GENETICS remains an essential resource for those dedicated to exploring the complexities of human heredity.

Molecular Genetics & Genomic Medicine

Empowering the future of genomic medicine.
Publisher: WILEYISSN: 2324-9269Frequency: 12 issues/year

Molecular Genetics & Genomic Medicine, published by WILEY, is an esteemed and open-access journal that has been a prominent source of knowledge in the fields of genetics and molecular biology since its establishment in 2013. With an ISSN of 2324-9269, it aims to provide a platform for the dissemination of novel findings and innovative research that pushes the boundaries of genomics and its clinical applications. The journal holds a Q3 categorization in Genetics, Clinical Genetics, and Molecular Biology, reflecting its growing influence in these disciplines, as evidenced by its Scopus rankings. Researchers, professionals, and students alike will find valuable insights and advancements in genomic medicine, making this journal an essential resource for those dedicated to the understanding and application of genetic and molecular research in healthcare. Located at 111 River St, Hoboken, NJ, Molecular Genetics & Genomic Medicine continues to foster a global dialogue within the scientific community, ensuring accessible knowledge for all.